What Is Happening in Drug Market?

The steps to reduce drug prices and eliminate substandard drugs caused confusion, which only intensified after the December devaluation of the manat.

Contrary to the statements of the authorities on the establishment of uniform drug prices, the prices of one and the same drugs in different pharmacies differ. The list of drugs that have single prices cannot be found anywhere.

Furthermore, steps to lower prices have led to a deficiency of a number of drugs.

For example, amlipin required to cure high blood pressure has disappeared.

On New Year's Eve there was a message on the prohibition of drugs of 844 names.

However, yesterday the Ministry of Health clarified that the ban applies not the entire drugs, but certain series of drugs imported without permission from the Ministry of Health and which have not passed the examination. This is stated in the report of Ministry of Health on 6 January.

But then the question arises. For example, injections are prohibited for Diprospan produced by Turkish manufacturers, and the same drug of Belgian production vanished even earlier, while there are no other analogs for this drug.

The ban also regards validol of Russian and Ukrainian production and citramon produced in Belarus. These drugs have been cheap enough and available for the poor.

In general, the number of banned drugs other than the above includes a variety of them imported from India, Romania, Denmark, Jordan, Georgia, Poland, Egypt, Germany and other countries.

After the second devaluation of December 21 drug prices have soared 1.7-2 times, although the rate of the manat dropped only by 50%.

Thus, the Cardiomagnyl taken by people with heart and blood pressure problems rose from 3.6 to 6.6 manat. The drug Prestarium, which until the second devaluation was worth 10 manat, has risen to 17 manat. Traktazim increased from 16 manat to 26 manat.

Many other cheap drugs also got 50-100% more expensive. -06D-